Makena $7.5M Product Liability Class Action Settlement
A $7.5 million settlement is available for those who used Makena (hydroxyprogesterone caproate injection) between March 2019 and July 2025.Summary
A $7.5 million class action settlement has been reached with Amag Pharmaceuticals Inc. regarding their drug Makena, used to reduce the risk of preterm birth. The lawsuit alleged misrepresentations about the drug’s effectiveness, and the FDA withdrew its approval in April 2023 after a study failed to confirm its benefits. Individuals who took, were prescribed, purchased, or paid out-of-pocket for Makena in the United States between March 8, 2019, and July 11, 2025, may be eligible for a claim.
Payout amounts vary based on documentation provided, ranging from $1 per treatment (with no proof) to full reimbursement of out-of-pocket costs (with proof of treatment and payment). Those with proof of treatment but no payment information may receive $22 per treatment. The settlement administrator will distribute funds after resolving any appeals and receiving final court approval.
The claim deadline is November 10, 2025. Claimants can file online, mail in a form, or request a form by phone or email. Proof of purchase, treatment, and out-of-pocket costs may be required depending on the desired reimbursement level. Funds will be distributed via PayPal, Venmo, Zelle, virtual prepaid card, or paper check.
(Source：Claim Depot)